JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases

• by Bingrun Li, Xiaoting Song, Cunhao Shan, Junchen He, Zihan Wang, Katarina Stevanovic, Torsten Zuberbier, Zuotao Zhao, Litao Zhang

• June 18, 2026

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

• by Andrea Surnit

• July 6, 2026

• 3 min

Calcium signaling in psoriasis: from pathogenesis to therapeutic opportunities

• by Y. X. Chen, D. X. Zhuo, F. F. Wang

• July 15, 2026

Efficacy and safety of upadacitinib in treating immune drift: a single-center, prospective study in China

• by Wanyan Xiang, Jiarong Lu, Siqi Zhang, Wenjun Zheng, Qiuju Li

• July 6, 2026